Abstract
Patients with early stage non small cell lung cancer (NSCLC) have historically been treated by resection alone, with results that have been superior to the results seen with radiation alone. This reflects the selection bias inherent to any comparison of operative and non-operative patients but surgery remains preferred treatment option. However, relapse rate after surgery is significant. In addition, a large proportion of these patients are not amenable to surgery due to medical co-morbidities and co-existing illnesses. These patients typically undergo a course of conventional radiotherapy, which provides poor outcomes both in terms of local control and survival. Attempts at dose escalation have met with some success, but local failures remain common and further dose escalation is limited by unacceptable toxicities. SRT allows for the delivery of a very high dose of radiation to a precise target. SRT presents the challenge of organ motion throughout the respiratory cycle. We review methods to mitigate this problem using both frame-based and frameless techniques, implanted fiducial markers, respiratory gating or deep inspiratory breath hold, and image guidance. Clinical experience with lung SRT continues to grow. Toxicities have been surprisingly mild. Based on available evidence, SRT appears to be effective, convenient and well tolerated.
Keywords: Lung cancer, radiosurgery, non small cell, body radiosurgery, extracranial radiosurgery
Current Cancer Therapy Reviews
Title: Emerging Role of Stereotactic Radiotherapy (SRT) in the Treatment of Early Stage Non-Small Cell Lung Cancer
Volume: 5 Issue: 4
Author(s): Joshua D. Lawson, Ajay Sandhu, Steve Jiang and Arno J. Mundt
Affiliation:
Keywords: Lung cancer, radiosurgery, non small cell, body radiosurgery, extracranial radiosurgery
Abstract: Patients with early stage non small cell lung cancer (NSCLC) have historically been treated by resection alone, with results that have been superior to the results seen with radiation alone. This reflects the selection bias inherent to any comparison of operative and non-operative patients but surgery remains preferred treatment option. However, relapse rate after surgery is significant. In addition, a large proportion of these patients are not amenable to surgery due to medical co-morbidities and co-existing illnesses. These patients typically undergo a course of conventional radiotherapy, which provides poor outcomes both in terms of local control and survival. Attempts at dose escalation have met with some success, but local failures remain common and further dose escalation is limited by unacceptable toxicities. SRT allows for the delivery of a very high dose of radiation to a precise target. SRT presents the challenge of organ motion throughout the respiratory cycle. We review methods to mitigate this problem using both frame-based and frameless techniques, implanted fiducial markers, respiratory gating or deep inspiratory breath hold, and image guidance. Clinical experience with lung SRT continues to grow. Toxicities have been surprisingly mild. Based on available evidence, SRT appears to be effective, convenient and well tolerated.
Export Options
About this article
Cite this article as:
Lawson D. Joshua, Sandhu Ajay, Jiang Steve and Mundt J. Arno, Emerging Role of Stereotactic Radiotherapy (SRT) in the Treatment of Early Stage Non-Small Cell Lung Cancer, Current Cancer Therapy Reviews 2009; 5 (4) . https://dx.doi.org/10.2174/157339409789712636
DOI https://dx.doi.org/10.2174/157339409789712636 |
Print ISSN 1573-3947 |
Publisher Name Bentham Science Publisher |
Online ISSN 1875-6301 |
Call for Papers in Thematic Issues
Current progress in Protein Degradation and Cancer Therapy
argeted Protein Degradation is gaining momentum in cancer therapy, it facilitate targeting undruggable proteins, it overcome cancer resistance and avoid undesirable side effects. Thus small molecules degraders have emerged as novel therapeutic strategy. Targeted protein degradation (TPD), the process of eliminating a protein of interest hold a great promise for ...read more
- Author Guidelines
- Graphical Abstracts
- Fabricating and Stating False Information
- Research Misconduct
- Post Publication Discussions and Corrections
- Publishing Ethics and Rectitude
- Increase Visibility of Your Article
- Archiving Policies
- Peer Review Workflow
- Order Your Article Before Print
- Promote Your Article
- Manuscript Transfer Facility
- Editorial Policies
- Allegations from Whistleblowers
Related Articles
-
Optical Image-Guided Cancer Therapy
Current Pharmaceutical Biotechnology MicroRNA-31 Inhibits Lung Adenocarcinoma Stem-Like Cells via Down-Regulation of MET-PI3K-Akt Signaling Pathway
Anti-Cancer Agents in Medicinal Chemistry A New Era of Immunotherapy in Prostate Cancer
Current Molecular Pharmacology Targeting Cyclooxygenase-2 in Hematological Malignancies: Rationale and Promise
Current Pharmaceutical Design Targeting the EGFR-family for Therapy: Biological Challenges and Clinical Perspective
Current Pharmaceutical Design Virotherapy as An Approach Against Cancer Stem Cells
Current Gene Therapy Androgen Pathway Related Gene Variants and Prostate Cancer Association in Auckland Men
Current Pharmacogenomics and Personalized Medicine Immunoliposomes in Acute Myeloid Leukaemia Therapy: An Overview of Possible Targets and Obstacles
Current Medicinal Chemistry Nanotechnology Applications for Diffuse Intrinsic Pontine Glioma
Current Neuropharmacology Monoclonal Antibody “Gold Rush”
Current Medicinal Chemistry RNA Silencing: Recent Developments on miRNAs
Recent Patents on DNA & Gene Sequences Drug-Related Cardiotoxicity for the Treatment of Haematological Malignancies in Elderly
Current Pharmaceutical Design Prognostic Parameters in Myeloid Malignancies in a Historical Context – From Microscopy to Individualized Medicine
Current Drug Targets Editorial from Guest Editor [Hot Topic:Vitamin D and Respiratory Health (Guest Editor: Adrian R. Martineau)]
Current Respiratory Medicine Reviews Role of Flavonoids in Future Anticancer Therapy by Eliminating the Cancer Stem Cells
Current Stem Cell Research & Therapy Targeting Angiogenic Pathways in Colorectal Cancer: Complexities, Challenges and Future Directions
Current Drug Targets Solvent-Free and Self-Catalyzed Three-Component Synthesis of Diversely Substituted Pyrazolo[1,4]thiazepinones of Potential Antitumor Activity
Current Organic Synthesis Towards Cure of CML: Why We Need to Know More About CML Stem Cells?
Current Stem Cell Research & Therapy Immunobiology of Antigen-Specific Immunoglobulin Free Light Chains in Chronic Inflammatory Diseases
Current Pharmaceutical Design A Case of Ischemic Stroke in Acute Promyelocytic Leukemia at Initial Presentation: Relevance of All-Trans Retinoic Acid Treatment
Cardiovascular & Hematological Disorders-Drug Targets